These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 20023690)

  • 1. Small-cell neuroendocrine carcinoma of the prostate: are heterotransplants a better experimental model?
    Lopez-Barcons LA
    Asian J Androl; 2010 May; 12(3):308-14. PubMed ID: 20023690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human benign prostatic hyperplasia heterotransplants as an experimental model.
    Lopez-Barcons LA
    Asian J Androl; 2010 Mar; 12(2):157-63. PubMed ID: 19946317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human prostate cancer heterotransplants: a review on this experimental model.
    Lopez-Barcons LA
    Asian J Androl; 2010 Jul; 12(4):509-18. PubMed ID: 20364154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FOXA2 is a sensitive and specific marker for small cell neuroendocrine carcinoma of the prostate.
    Park JW; Lee JK; Witte ON; Huang J
    Mod Pathol; 2017 Sep; 30(9):1262-1272. PubMed ID: 28621319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A neuroendocrine/small cell prostate carcinoma xenograft-LuCaP 49.
    True LD; Buhler K; Quinn J; Williams E; Nelson PS; Clegg N; Macoska JA; Norwood T; Liu A; Ellis W; Lange P; Vessella R
    Am J Pathol; 2002 Aug; 161(2):705-15. PubMed ID: 12163395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Models of neuroendocrine prostate cancer.
    Berman-Booty LD; Knudsen KE
    Endocr Relat Cancer; 2015 Feb; 22(1):R33-49. PubMed ID: 25349195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroendocrine differentiation in the 12T-10 transgenic prostate mouse model mimics endocrine differentiation of pancreatic beta cells.
    Gupta A; Wang Y; Browne C; Kim S; Case T; Paul M; Wills ML; Matusik RJ
    Prostate; 2008 Jan; 68(1):50-60. PubMed ID: 18004726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serially heterotransplanted human prostate tumours as an experimental model.
    Lopez-Barcons LA
    J Cell Mol Med; 2010 Jun; 14(6B):1385-95. PubMed ID: 19874422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroendocrine prostate cancer xenografts with large-cell and small-cell features derived from a single patient's tumor: morphological, immunohistochemical, and gene expression profiles.
    Aparicio A; Tzelepi V; Araujo JC; Guo CC; Liang S; Troncoso P; Logothetis CJ; Navone NM; Maity SN
    Prostate; 2011 Jun; 71(8):846-56. PubMed ID: 21456067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate carcinoma with amphicrine features: further refining the spectrum of neuroendocrine differentiation in tumours of primary prostatic origin?
    Prendeville S; Al-Bozom I; Compérat E; Sweet J; Evans AJ; Ben-Gashir M; Mete O; van der Kwast TH; Downes MR
    Histopathology; 2017 Dec; 71(6):926-933. PubMed ID: 28756619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A probasin-large T antigen transgenic mouse line develops prostate adenocarcinoma and neuroendocrine carcinoma with metastatic potential.
    Masumori N; Thomas TZ; Chaurand P; Case T; Paul M; Kasper S; Caprioli RM; Tsukamoto T; Shappell SB; Matusik RJ
    Cancer Res; 2001 Mar; 61(5):2239-49. PubMed ID: 11280793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulinoma-associated protein 1 is a novel sensitive and specific marker for small cell carcinoma of the prostate.
    Xin Z; Zhang Y; Jiang Z; Zhao L; Fan L; Wang Y; Xie S; Shangguan X; Zhu Y; Pan J; Liu Q; Huang Y; Dong B; Xue W
    Hum Pathol; 2018 Sep; 79():151-159. PubMed ID: 29885405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SIRT7 depletion inhibits cell proliferation and androgen-induced autophagy by suppressing the AR signaling in prostate cancer.
    Ding M; Jiang CY; Zhang Y; Zhao J; Han BM; Xia SJ
    J Exp Clin Cancer Res; 2020 Feb; 39(1):28. PubMed ID: 32019578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular characterization of prostatic small-cell neuroendocrine carcinoma.
    Clegg N; Ferguson C; True LD; Arnold H; Moorman A; Quinn JE; Vessella RL; Nelson PS
    Prostate; 2003 Apr; 55(1):55-64. PubMed ID: 12640661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroendocrine prostate cancer (NEPCa) increased the neighboring PCa chemoresistance via altering the PTHrP/p38/Hsp27/androgen receptor (AR)/p21 signals.
    Cui Y; Sun Y; Hu S; Luo J; Li L; Li X; Yeh S; Jin J; Chang C
    Oncogene; 2016 Nov; 35(47):6065-6076. PubMed ID: 27375022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-cadherin increases after androgen deprivation and is associated with metastasis in prostate cancer.
    Jennbacken K; Tesan T; Wang W; Gustavsson H; Damber JE; Welén K
    Endocr Relat Cancer; 2010 Jun; 17(2):469-79. PubMed ID: 20233707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein arginine methyltransferase 5 functions as an epigenetic activator of the androgen receptor to promote prostate cancer cell growth.
    Deng X; Shao G; Zhang HT; Li C; Zhang D; Cheng L; Elzey BD; Pili R; Ratliff TL; Huang J; Hu CD
    Oncogene; 2017 Mar; 36(9):1223-1231. PubMed ID: 27546619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NE-10 neuroendocrine cancer promotes the LNCaP xenograft growth in castrated mice.
    Jin RJ; Wang Y; Masumori N; Ishii K; Tsukamoto T; Shappell SB; Hayward SW; Kasper S; Matusik RJ
    Cancer Res; 2004 Aug; 64(15):5489-95. PubMed ID: 15289359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Androgen Deprivation Therapy Potentiates the Efficacy of Vascular Targeted Photodynamic Therapy of Prostate Cancer Xenografts.
    Kim K; Watson PA; Lebdai S; Jebiwott S; Somma AJ; La Rosa S; Mehta D; Murray KS; Lilja H; Ulmert D; Monette S; Scherz A; Coleman JA
    Clin Cancer Res; 2018 May; 24(10):2408-2416. PubMed ID: 29463549
    [No Abstract]   [Full Text] [Related]  

  • 20. An allograft model of androgen independent prostatic neuroendocrine carcinoma derived from a large probasin promoter-T antigen transgenic mouse line.
    Masumori N; Tsuchiya K; Tu WH; Lee C; Kasper S; Tsukamoto T; Shappell SB; Matusik RJ
    J Urol; 2004 Jan; 171(1):439-42. PubMed ID: 14665950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.